Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
This course provides a comprehensive overview of the treatment of cancer for the advanced practice provider, including important concepts related to antineoplastics, chemotherapy, immunotherapy, surgical oncology, radiation oncology, hematopoietic stem cell transplantation, goals of therapy, clinical trials, and treatment response.
The ONS Oncology Nurse Orientation Program, provides didactic content for nurses new to oncology. The course is evidence-based, incorporates ONS standards and guidelines, and supports new oncology nurses working toward certification based on the ONS Oncology Nurse Generalist Competencies.
This redesigned and updated program was created with the new oncology advanced practice provider in mind. Through a series of four online courses, learners will get a comprehensive look at of the basics of cancer and its treatment, symptom and side effect management, and the identification of and management of oncologic emergencies with content designed for the advanced practice provider.
Patients with uveal melanoma who were treated with tebentafusp, an investigational immunotherapy, lived a median 5.7 months longer than those in comparison groups, researchers reported in study findings presented at the American Association for Cancer Research 2021 annual meeting.
Using two agents that target two different receptors more than doubles length of survival for advanced melanoma than a single agent alone, researchers reported at the 2021 American Society of Clinical Oncology annual meeting.
Patients with melanoma who consume a high-fiber diet during treatment with immune checkpoint inhibitors (ICIs) or anti-PD-1 therapy experience longer progression-free survival than those who don’t, researchers reported in Science. And probiotic supplementation, often considered a healthy behavior, reduces immunotherapy response.
Growing evidence suggests that the gut microbiome, a diverse and complex mix of microorganisms and their metabolites, is closely linked to the immune system, and researchers are studying whether modulating the gut microbiome affects cancer immunotherapy treatment outcomes. In particular, probiotics—which are flora typically obtained through dietary sources such as yogurt and fermented foods or via supplemental forms—are gaining prominence as a potential strategy to modulate the gut microbiome during cancer treatment.